Treatment of the cells from HT patients with low concentrations of Tg1/2 chimeric molecules achieved suppression of the Tg-specific plasma cells compared to PBMCs treated with Control chimera and CpG + LPS control cells (significance at 8 ng/mL, Figure 5, left panel). This evidence concerns the gene TG and hematocrit.